These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 12598334)

  • 1. Oligomer-mediated modulation of hTERT alternative splicing induces telomerase inhibition and cell growth decline in human prostate cancer cells.
    Brambilla C; Folini M; Gandellini P; Daprai L; Daidone MG; Zaffaroni N
    Cell Mol Life Sci; 2004 Jul; 61(14):1764-74. PubMed ID: 15241552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and Emerging Biomarkers: Impact on Risk Stratification for Neuroblastoma.
    Irwin MS; Goldsmith KC
    J Natl Compr Canc Netw; 2024 Aug; 22(6):. PubMed ID: 39151453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TERT-Regulation and Roles in Cancer Formation.
    Dratwa M; Wysoczańska B; Łacina P; Kubik T; Bogunia-Kubik K
    Front Immunol; 2020; 11():589929. PubMed ID: 33329574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative splicing of human telomerase reverse transcriptase in gliomas and its modulation mediated by CX-5461.
    Li G; Shen J; Cao J; Zhou G; Lei T; Sun Y; Gao H; Ding Y; Xu W; Zhan Z; Chen Y; Huang H
    J Exp Clin Cancer Res; 2018 Apr; 37(1):78. PubMed ID: 29631594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous regression of neuroblastoma.
    Brodeur GM
    Cell Tissue Res; 2018 May; 372(2):277-286. PubMed ID: 29305654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of
    Ashtiani M; Nabatchian F; Galavi HR; Saravani R; Farajian-Mashhadi F; Salimi S
    Biomed Rep; 2017 Sep; 7(3):251-256. PubMed ID: 28811896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative Splicing of hTERT Pre-mRNA: A Potential Strategy for the Regulation of Telomerase Activity.
    Liu X; Wang Y; Chang G; Wang F; Wang F; Geng X
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28272339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stage 4S neuroblastoma tumors show a characteristic DNA methylation portrait.
    Decock A; Ongenaert M; De Wilde B; Brichard B; Noguera R; Speleman F; Vandesompele J
    Epigenetics; 2016 Oct; 11(10):761-771. PubMed ID: 27599161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of neuroblastoma regression.
    Brodeur GM; Bagatell R
    Nat Rev Clin Oncol; 2014 Dec; 11(12):704-13. PubMed ID: 25331179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G-quadruplexes as potential therapeutic targets for embryonal tumors.
    Shalaby T; Fiaschetti G; Nagasawa K; Shin-ya K; Baumgartner M; Grotzer M
    Molecules; 2013 Oct; 18(10):12500-37. PubMed ID: 24152672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oct-4+/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells.
    Pezzolo A; Parodi F; Marimpietri D; Raffaghello L; Cocco C; Pistorio A; Mosconi M; Gambini C; Cilli M; Deaglio S; Malavasi F; Pistoia V
    Cell Res; 2011 Oct; 21(10):1470-86. PubMed ID: 21403679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase detection in the diagnosis and prognosis of cancer.
    Hiyama E; Hiyama K
    Cytotechnology; 2004 Jun; 45(1-2):61-74. PubMed ID: 19003244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of GD2-positive cells in bone marrow samples and survival of patients with localised neuroblastoma.
    Corrias MV; Parodi S; Haupt R; Lacitignola L; Negri F; Sementa AR; Dau D; Scuderi F; Carlini B; Bianchi M; Casale F; Faulkner L; Garaventa A
    Br J Cancer; 2008 Jan; 98(2):263-9. PubMed ID: 18182983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer.
    Zhu CQ; Cutz JC; Liu N; Lau D; Shepherd FA; Squire JA; Tsao MS
    Br J Cancer; 2006 May; 94(10):1452-9. PubMed ID: 16641908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of telomerase activation by v-Rel and its contribution to transformation.
    Hrdlicková R; Nehyba J; Liss AS; Bose HR
    J Virol; 2006 Jan; 80(1):281-95. PubMed ID: 16352553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of human telomerase reverse transcriptase mRNA expression in individual blastomeres as an indicator of early embryo development.
    Wang CW; Yao DS; Horng SG; Chiu HC; Chen CK; Lee CL; Huang HY; Wang HS; Soong YK; Pao CC
    J Assist Reprod Genet; 2004 May; 21(5):163-8. PubMed ID: 15279323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proliferation and hTERT expression in neuroblastoma].
    Krams M; Rudolph P; Harms D
    Pathologe; 2004 Jul; 25(4):317-23. PubMed ID: 15168079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Full-length telomerase reverse transcriptase messenger RNA is an independent prognostic factor in neuroblastoma.
    Krams M; Hero B; Berthold F; Parwaresch R; Harms D; Rudolph P
    Am J Pathol; 2003 Mar; 162(3):1019-26. PubMed ID: 12598334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of telomerase activity by alternate splicing of human telomerase reverse transcriptase mRNA in a subset of neuroblastomas.
    Krams M; Claviez A; Heidorn K; Krupp G; Parwaresch R; Harms D; Rudolph P
    Am J Pathol; 2001 Nov; 159(5):1925-32. PubMed ID: 11696453
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.